Nanomedicine Market Size, Competitors Strategy, Regional Analysis and Industry Growth by Forecast to 2028

 The global nanomedicine market is expected to reach USD 435.08 billion by 2028, according to a new report by Reports and Data. Increased global incidence of cancer coupled with growing prevalence of cardiovascular diseases is likely to be the key factors governing market growth. Based on the WHO statistics, in 2018 around 18.07million new cases were registered for cancer in 2018. Additionally, cancer accounted for around 9.5 million deaths in 2018. The incidence of cancer was significantly high and lied around 48.4 percent in Asia Pacific.

Nanomedicine is being increasingly adopted for the treatment of various diseases including cancer and cardiovascular disease. Apart from improved efficacy and safety, factors such as bio-availability and ability to deliver diagnostic and therapeutic agents to targeted sites are expected to stimulate market growth.

Asia Pacific is expected to be a key revenue generating region in the forecast period. The market is projected to grow at a CAGR of 13.8% in the forecast period. This can be mainly associated with increasing incidence of cancer in the region. Based on estimates, along with high incidence of cancer as compared to other regions, the mortality rate of cancer in Asia is also significantly high. In 2018, the mortality rate was around 57.3 percent for Asia Pacific while it was around 20.3 percent for Europe. Increasing number of deaths of cancer patients is likely to lead to a rise in the adoption of nanomedicine in the region. Moreover, success of nanomedicines in the treatment of heart diseases is also expected to be a major factor affecting demand in the region.

Get a sample of the report @

The companies operating in the market and profiled in the report include

Arrowhead Pharmaceuticals Inc. AMAG Pharmaceuticals, Bio-Gate AG, Celgene Corporation and Johnson & Johnson. Johnson & Johnson is a key player in the nanomedicine market.

The report offers complete portfolios of the key companies operating in the market including production capacity, revenue share and size, gross margin, sales revenue and margin, business expansion plans, technological advancements, product portfolio, global market position, and financial standing. The report also discusses in detail the recent mergers and acquisitions, joint ventures, product launches and brand promotions, partnerships, collaborations, agreements, and corporate and government deals.

The report further discusses in detail the market segmentation

Product Outlook (Revenue, USD Billion, 2018-2028)

  • Therapeutics
  • Regenerative Medicine
  • In-vitro diagnostics
  • In-vivo diagnostic
  • Vaccines

Drug Delivery System Outlook (Revenue, USD Billion, 2018-2028)

    • Nanobots
    • Nanoghosts
    • Nanoclusters
    • Nanobubbles
    • Exosomes
    • Injectable Nanoparticle Generator
    • Dendrimers
    • Liposomes
    • Carbon nanotube
    • Graphene
    • Others

Application Outlook (Revenue, USD Million, 2018-2028)

    • Oncology
    • Infectious diseases
    • Cardiology
    • Orthopedics
    • Others

Request a discount on the report @

The report focuses on evaluation of the Nanomedicine market in major regions and the countries included in those regions. The report evaluates the key aspects of the global market such as production and consumption patterns, supply and demand ratio, import and export, economic growth, technological developments, and robust presence of key players in the region. The report also offers a country wise analysis to offer better information about the Nanomedicine market scope in key regions and crucial factors influencing market growth in major countries. Regional analysis covers the following:

  • North America
    • Canada
    • U.S.
    • Mexico
  • Europe
    • Germany
    • Italy
    • U.K.
    • Rest of EU
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • A.E
    • Rest of MEA

To know more about the report @

Key Advantages of the Nanomedicine Market Report:

  • Detailed analysis of changing dynamics of the global Nanomedicine market
  • Valuable insights on key market growth driving trends and monetary competence over the forecast period
  • SWOT analysis and Porter’s Five Forces analysis for each key market player to offer competitive advantage to readers and investors
  • Comprehensive assessment of competitive landscape and regional analysis
  • Assessment of key factors driving and restraining market growth
  • Analysis of threats, limitations, growth prospects, opportunities, and barriers in the market
  • Strategic recommendations to key market players and new entrants to assist them in gaining a robust footing in the market

Request a customization of the report @

Thank you for reading our report. Customization of this report is available according to the requirement of the clients. For further query or information regarding this report, please get in touch with us and team will ensure your doubts are cleared.

Explore our related report from different Publications:

Oligonucleotide Synthesis Market @

Robotic Rehabilitation and Assistive Technologies Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370

E-mail: [email protected]